Colgate-Palmolive Could Stabilize US Business in 2027, RBC Says

MT Newswires Live09-08 23:40

Colgate-Palmolive's (CL) US business could start stabilizing in Q1 2027 as it benefits from lapping its "self-inflicted" missteps and narrowing share losses, but significant reacceleration will require tougher choices, such as launching a new US brand, RBC Capital Markets said in a Tuesday research report.

The company's international business has consistently delivered mid-to-high single-digit organic growth, while the US business has capped further upside, the investment firm said.

RBC said competitive encroachment and innovation gaps in whitening and premium therapeutics have contributed to the company's US business underperformance, which produced negative organic sales for most of the past two years.

The Colgate Total relaunch addresses the short-term urgency, but it is working within the limits of a single brand attempting to occupy both mainstream and therapeutic positioning at the same time, which is a structural limitation its European two-brand playbook was specifically designed to solve, according to the note.

RBC has an outperform rating and a $104 price target on the company's stock.

Price: 88.11, Change: -0.66, Percent Change: -0.74

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2665737929?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-08 23:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2665737929","market":"fut","top_or_hot":-1,"title":"Colgate-Palmolive Could Stabilize US Business in 2027, RBC Says","media":"MT Newswires Live","content":"<html><body><p> Colgate-Palmolive's (CL) US business could start stabilizing in Q1 2027 as it benefits from lapping its \"self-inflicted\" missteps and narrowing share losses, but significant reacceleration will require tougher choices, such as launching a new US brand, RBC Capital Markets said in a Tuesday research report.</p><p>The company's international business has consistently delivered mid-to-high single-digit organic growth, while the US business has capped further upside, the investment firm said.</p><p>RBC said competitive encroachment and innovation gaps in whitening and premium therapeutics have contributed to the company's US business underperformance, which produced negative organic sales for most of the past two years.</p><p>The Colgate Total relaunch addresses the short-term urgency, but it is working within the limits of a single brand attempting to occupy both mainstream and therapeutic positioning at the same time, which is a structural limitation its European two-brand playbook was specifically designed to solve, according to the note.</p><p>RBC has an outperform rating and a $104 price target on the company's stock.</p><p>Price: 88.11, Change: -0.66, Percent Change: -0.74</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Colgate-Palmolive Could Stabilize US Business in 2027, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColgate-Palmolive Could Stabilize US Business in 2027, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-08 23:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Colgate-Palmolive's (CL) US business could start stabilizing in Q1 2027 as it benefits from lapping its \"self-inflicted\" missteps and narrowing share losses, but significant reacceleration will require tougher choices, such as launching a new US brand, RBC Capital Markets said in a Tuesday research report.</p><p>The company's international business has consistently delivered mid-to-high single-digit organic growth, while the US business has capped further upside, the investment firm said.</p><p>RBC said competitive encroachment and innovation gaps in whitening and premium therapeutics have contributed to the company's US business underperformance, which produced negative organic sales for most of the past two years.</p><p>The Colgate Total relaunch addresses the short-term urgency, but it is working within the limits of a single brand attempting to occupy both mainstream and therapeutic positioning at the same time, which is a structural limitation its European two-brand playbook was specifically designed to solve, according to the note.</p><p>RBC has an outperform rating and a $104 price target on the company's stock.</p><p>Price: 88.11, Change: -0.66, Percent Change: -0.74</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1236620750.USD","symbol_name":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (USD) INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2665737929","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2665737929","pubTimestamp":1788882040,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Colgate-Palmolive's  US business could start stabilizing in Q1 2027 as it benefits from lapping its \"self-inflicted\" missteps and narrowing share losses, but significant reacceleration will require tougher choices, such as launching a new US brand, RBC Capital Markets said in a Tuesday research report.The company's international business has consistently delivered mid-to-high single-digit organic growth, while the US business has capped further upside, the investment firm said.RBC said competitive encroachment and innovation gaps in whitening and premium therapeutics have contributed to the company's US business underperformance, which produced negative organic sales for most of the past two years.The Colgate Total relaunch addresses the short-term urgency, but it is working within the limits of a single brand attempting to occupy both mainstream and therapeutic positioning at the same time, which is a structural limitation its European two-brand playbook was specifically designed to s","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1236620750.USD":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (USD) INC","BK4018":"居家用品","LU1150488135.SGD":"First Eagle Amundi Income Builder AHS-MD SGD-H","BK4585":"ETF&股票定投概念","LU1236620834.HKD":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (HKD) INC","LU2125154935.USD":"ALLSPRING (LUX) WF GLOBAL EQUITY ENHANCED INCOME \"I\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","CL":"高露洁","LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","BK4504":"桥水持仓","LU1599440770.SGD":"FIDELITY GLOBAL DIVIDEND \"A\" (SGDHDG) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4532":"文艺复兴科技持仓","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","BK4588":"碎股","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU1150488218.USD":"First Eagle Amundi Income Builder AU2-MD USD","LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","LU0731783394.SGD":"Fidelity Global Dividend A-MINCOME(G)-SGD","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU1675838814.USD":"AB SICAV I - EMERGING MARKETS LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC"},"translate_title":"加拿大皇家银行表示，高露洁棕榄可能会在 2027 年稳定美国业务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CL":1.5},"content_text":"Colgate-Palmolive's (CL) US business could start stabilizing in Q1 2027 as it benefits from lapping its \"self-inflicted\" missteps and narrowing share losses, but significant reacceleration will require tougher choices, such as launching a new US brand, RBC Capital Markets said in a Tuesday research report.The company's international business has consistently delivered mid-to-high single-digit organic growth, while the US business has capped further upside, the investment firm said.RBC said competitive encroachment and innovation gaps in whitening and premium therapeutics have contributed to the company's US business underperformance, which produced negative organic sales for most of the past two years.The Colgate Total relaunch addresses the short-term urgency, but it is working within the limits of a single brand attempting to occupy both mainstream and therapeutic positioning at the same time, which is a structural limitation its European two-brand playbook was specifically designed to solve, according to the note.RBC has an outperform rating and a $104 price target on the company's stock.Price: 88.11, Change: -0.66, Percent Change: -0.74","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2665737929","isCrawlerRequest":true}